FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC

Horizon Therapeutics

16/05/2023 15:36

May 16 (Reuters) - Commissioners at the U.S. Federal
Trade Commission (FTC) have not yet met to discuss Amgen's
 AMGN.O  acquisition of Horizon Therapeutics  HZNP.O , CNBC
reported on Tuesday.
    The news comes a day after reports that the FTC is expected
to file a lawsuit as early as Tuesday to block the $27.8 billion
deal.

 (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))